BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3953366)

  • 1. Renal effects of nicardipine in patients with mild-to-moderate essential hypertension.
    Baba T; Boku A; Ishizaki T; Sone K; Takebe K
    Am Heart J; 1986 Mar; 111(3):552-7. PubMed ID: 3953366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal effects of nicardipine, a calcium entry blocker, in hypertensive type II diabetic patients with nephropathy.
    Baba T; Ishizaki T; Ido Y; Aoyagi K; Murabayashi S; Takebe K
    Diabetes; 1986 Nov; 35(11):1206-14. PubMed ID: 3530849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple oral doses of nicardipine, a calcium-entry blocker: effects on renal function, plasma renin activity, and aldosterone concentration in mild-to-moderate essential hypertension.
    Baba T; Ishizaki T; Murabayashi S; Aoyagi K; Tamasawa N; Takebe K
    Clin Pharmacol Ther; 1987 Aug; 42(2):232-9. PubMed ID: 3301155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive and renal effects of nicardipine.
    van Schaik BA; van Nistelrooy AE; Geyskes GG
    Br J Clin Pharmacol; 1984 Jul; 18(1):57-63. PubMed ID: 6743490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute and chronic effects of a new calcium blocker, nicardipine, on renal hemodynamics in arterial hypertension].
    Chaignon M; Bellet M; Lucsko M; Rapoud C; Guédon J
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1642-6. PubMed ID: 3938234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a calcium-entry blocker, nicardipine, on intrarenal hemodynamics in essential hypertension.
    Kimura G; Deguchi F; Kojima S; Ashida T; Yoshimi H; Abe H; Kawano Y; Yoshida K; Kawamura M; Imanishi M
    Am J Kidney Dis; 1991 Jan; 17(1):47-54. PubMed ID: 1986570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CV-4093, a new dihydropyridine calcium channel blocker, on renal hemodynamics and function in stroke-prone spontaneously hypertensive rats (SHRSP).
    Morimoto S; Ohyama T; Hisaki K; Matsumura Y
    Jpn J Pharmacol; 1989 Oct; 51(2):257-65. PubMed ID: 2593383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of acute and chronic nicardipine therapy on forearm arterial haemodynamics in essential hypertension.
    Levenson J; Simon AC; Bouthier J; Maarek BC; Safar ME
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):107S-113S. PubMed ID: 4027144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal effects of nicardipine, a calcium antagonist, in hypertensive type 2 (non-insulin-dependent) diabetic patients with and without nephropathy.
    Baba T; Tomiyama T; Murabayashi S; Takebe K
    Eur J Clin Pharmacol; 1990; 38(5):425-9. PubMed ID: 2379527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects of intravenous nifedipine on renal function.
    Yokoyama S; Kaburagi T
    J Cardiovasc Pharmacol; 1983; 5(1):67-71. PubMed ID: 6186862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effect of calcium blocker on renal hemodynamics in diabetic spontaneously hypertensive rat.
    Kaizu K; Ling QY; Uriu K; Ikeda M; Eto S
    J Diabetes Complications; 1995; 9(4):301-3. PubMed ID: 8573752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial.
    Baba T; Murabayashi S; Takebe K
    Diabetologia; 1989 Jan; 32(1):40-4. PubMed ID: 2540054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of intravenous nicardipine hydrochloride (YC 93), a calcium antagonist, on renal function (author's transl)].
    Yokoyama S; Kaburagi T
    Nihon Jinzo Gakkai Shi; 1981 Aug; 23(8):1143-51. PubMed ID: 7321319
    [No Abstract]   [Full Text] [Related]  

  • 14. Amlodipine therapy corrects renal abnormalities encountered in the hypertensive state.
    Reams GP; Lau A; Hamory A; Bauer JH
    Am J Kidney Dis; 1987 Dec; 10(6):446-51. PubMed ID: 2961256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic (systemic and renal) and humoral interactions between nicardipine and domperidone in hypertensives.
    Lucarini AR; Salvetti A
    J Hypertens Suppl; 1987 Dec; 5(5):S571-4. PubMed ID: 3327930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the calcium antagonist nicardipine on renal function and renin release in dogs.
    Abe Y; Komori T; Miura K; Takada T; Imanishi M; Okahara T; Yamamoto K
    J Cardiovasc Pharmacol; 1983; 5(2):254-9. PubMed ID: 6188899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acute haemodynamic effects of nicardipine in patients with chronic left ventricular failure.
    Greenbaum RA; Wan S; Evans TR
    Eur J Clin Pharmacol; 1986; 30(4):383-6. PubMed ID: 3743613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal effects of nitrendipine monotherapy in essential hypertension.
    Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1032-6. PubMed ID: 6085362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of manidipine, a new calcium antagonist, on intrarenal hemodynamics in essential hypertension.
    Murakami K; Kimura G; Imanishi M; Sanai T; Kawano Y; Kojima S; Yoshida K; Abe H; Ashida T; Yoshimi H
    Blood Press Suppl; 1992; 3():114-8. PubMed ID: 1343278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal effects of bunazosin, a new alpha 1-adrenoceptor blocker, in patients with mild-to-moderate essential hypertension.
    Baba T; Tomiyama T; Murabayashi S; Takebe K
    J Cardiovasc Pharmacol; 1990 May; 15(5):826-30. PubMed ID: 1692944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.